Pain Medicine · Greensboro, NC
NPI
1275511966
Since 2006
Specialty
Pain Medicine
Code 208VP0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
522 N Elam Ave, Ste 203
Greensboro, NC, 27403
Phone (336) 852-8444
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,311 services
Medicare patients, 2024
112
Average age 72
Drug cost, 2024
$608K
6,274 prescriptions
Company payments, 2025
$571
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark L Phillips was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 542 times for 98 patients. In total Mark L Phillips billed 1,311 services in 10 codes, and Medicare paid $57K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-03-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 542 | 98 | $12.47 | $6,757 |
| 99214 Office E&M - Established | Office | 345 | 96 | $88.98 | $31K |
| 99213 Office E&M - Established | Office | 277 | 81 | $61.04 | $17K |
| 80305 Drug Tests | Office | 91 | 75 | $12.35 | $1,124 |
| 99204 Office E&M - New | Office | 11 | 11 | $125.36 | $1,379 |
By year: 2022 $67K for 1,020 services; 2023 $60K for 925 services; 2024 $57K for 1,311 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 91 | 75 | $12.35 | $1,124 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark L Phillips prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 686 prescriptions and refills. In total Mark L Phillips wrote 6,274 Medicare prescriptions that cost $608K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 686 | 686 | 89 | $28K |
| Oxycodone Hcl Generic | 638 | 639 | 74 | $15K |
| Morphine Sulfate Er Morphine Sulfate | 534 | 541 | 58 | $24K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 494 | 506 | 75 | $18K |
| Gabapentin Generic | 453 | 683 | 87 | $11K |
| Pregabalin Generic | 273 | 302 | 41 | $4,289 |
| Cyclobenzaprine Hcl Generic | 271 | 309 | 51 | $3,974 |
| Hydromorphone Hcl Generic | 200 | 200 | 27 | $3,977 |
| Tizanidine Hcl Generic | 197 | 291 | 38 | $4,719 |
| Morphine Sulfate Generic | 191 | 199 | 23 | $8,251 |
| Tramadol Hcl Generic | 160 | 160 | 27 | $2,361 |
| Methocarbamol Generic | 148 | 169 | 35 | $1,647 |
| Fentanyl Generic | 139 | 139 | 14 | $22K |
| Duloxetine Hcl Generic | 117 | 131 | 17 | $1,990 |
| Methadone Hcl Generic | 102 | 102 | Under 11 | $2,232 |
Brand drugs: 617 claims; generic drugs: 5,657 claims; opioid claims: 3,535.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark L Phillips $571 ($571 in general payments such as food, travel and fees) from 9 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $124.
| Company | Payments | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 5 | $124 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $100 |
| Pfizer Inc. PFE | 4 | $77.84 |
| Lundbeck LLC | 3 | $62.26 |
| Virtus Pharmaceuticals LLC | 2 | $44.18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $44.03 |
| Valinor Pharma, LLC | 2 | $43.73 |
| Abbvie Inc. ABBV | 2 | $39.09 |
| Boston Scientific Corporation BSX | 1 | $35.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.